|
1
|
Cerutti H and Casas-Mollano JA: On the
origin and functions of RNA-mediated silencing: from protists to
man. Curr Genet. 50:81–99. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Peng JJ, Yan F, Chen HR and Chen JP:
Progress of studies on Dicer structure and function. Yi Chuan.
30:1550–1556. 2008.(In Chinese).
|
|
3
|
Lee YS, Nakahara K, Pham JW, et al:
Distinct roles for Drosophila Dicer-1 and Dicer-2 in the
siRNA/miRNA silencing pathways. Cell. 117:69–81. 2004.
|
|
4
|
Filipowicz W, Jaskiewicz L, Kolb FA and
Pillai RS: Post-transcriptional gene silencing by siRNAs and
miRNAs. Curr Opin Struct Biol. 15:331–341. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chiosea S, Jelezcova E, Chandran U, et al:
Up-regulation of dicer, a component of the MicroRNA machinery, in
prostate adenocarcinoma. Am J Pathol. 169:1812–1820. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chiosea S, Jelezcova E, Chandran U, et al:
Overexpression of Dicer in precursor lesions of lung
adenocarcinoma. Cancer Res. 67:2345–2350. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Merritt WM, Lin YG, Han LY, et al: Dicer,
Drosha, and outcomes in patients with ovarian cancer. N Engl J Med.
359:2641–2650. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karube Y, Tanaka H, Osada H, et al:
Reduced expression of Dicer associated with poor prognosis in lung
cancer patients. Cancer Sci. 96:111–115. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Grelier G, Voirin N, Ay AS, et al:
Prognostic value of Dicer expression in human breast cancers and
association with the mesenchymal phenotype. Br J Cancer.
101:673–683. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zighelboim I, Reinhart AJ, Gao F, et al:
DICER1 expression and outcomes in endometrioid endometrial
adenocarcinoma. Cancer. 117:1446–1453. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Faber C, Horst D, Hlubek F and Kirchner T:
Overexpression of Dicer predicts poor survival in colorectal
cancer. Eur J Cancer. 47:1414–1419. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vaksman O, Hetland TE, Trope’ CG, et al:
Argonaute, Dicer, and Drosha are up-regulated along tumor
progression in serous ovarian carcinoma. Hum Pathol. 43:2062–2069.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ross J, Bottardi S, Bourgoin V,
Wollenschlaeger A, Drobetsky E, et al: Differential requirement of
a distal regulatory region for pre-initiation complex formation at
globin gene promoters. Nucleic Acids Res. 37:5295–5308. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Wang E, Dutta S, Lau JS, Jiang SW,
et al: Protein kinase C-mediated modulation of FIH-1 expression by
the home-odomain protein CDP/Cut/Cux. Mol Cell Biol. 27:7345–7353.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Harigae H: GATA transcription factors and
hematological diseases. Tohoku J Exp Med. 210:1–9. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shimizu R and Yamamoto M: Function and
gene expression regulation of GATA-1 and GATA-2 transcription.
Seikagaku. 79:941–952. 2007.(In Japanese).
|
|
17
|
Shimamoto T, Ohyashiki JH, Ohyashiki K, et
al: GATA-1, GATA-2, and stem cell leukemia gene expression in acute
myeloid leukemia. Leukemia. 8:1176–1180. 1994.PubMed/NCBI
|
|
18
|
Guerrasio A, Saglio G, Rosso C, et al:
Expression of GATA-1 mRNA in human myeloid leukemic cells.
Leukemia. 8:1034–1038. 1994.PubMed/NCBI
|
|
19
|
Shimamoto T, Ohyashiki K, Ohyashiki JH, et
al: The expression pattern of erythrocyte/megakaryocytes-related
transcription factors GATA-1 and stem cell leukemia gene correlates
with hematopoietic differentiation and is associated with outcome
of acute myeloid leukemia. Blood. 86:3173–3180. 1995.
|
|
20
|
Ayala RM, Martínez-López J, Albízua E, et
al: Clinical significance of Gata-1, Gata-2, EKLF, and c-MPL
expression in acute myeloid leukemia. Am J Hematol. 84:79–86. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ohyashiki K, Ohyashiki JH, Shimamoto T and
Toyama K: Pattern of expression and their clinical implications of
the GATA family, stem cell leukemia gene, and EVI1 in leukemia and
myelodysplastic syndromes. Leuk Lymphoma. 23:431–436. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Papachristou DJ, Korpetinou A,
Giannopoulou E, et al: Expression of the ribonucleases Drosha,
Dicer, and Ago2 in colorectal carcinomas. Virchows Arch.
459:431–440. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou Y, Chen L, Barlogie B, Stephens O, Wu
X, Williams DR, et al: High-risk myeloma is associated with global
elevation of miRNAs and overexpression of EIF2C2/AGO2. Proc Natl
Acad Sci USA. 107:7904–7909. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jakymiw A, Patel RS, Deming N, et al:
Overexpression of Dicer as a result of reduced let-7 microRNA
levels contributes to increased cell proliferation of oral cancer
cells. Genes Chromosomes Cancer. 49:549–559. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wiesen JL and Tomasi TB: Dicer is
regulated by cellular stresses and interferons. Mol Immunol.
46:1222–1228. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Levy C, Khaled M, Robinson KC, et al:
Lineage-specific transcriptional regulation of DICER by MITF in
melanocytes. Cell. 141:994–1005. 2010. View Article : Google Scholar : PubMed/NCBI
|
